These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1101580)

  • 1. Minimal inhibitory dosage of rifampicin in intermittent treatment of Mycobacterium leprae infection in mice.
    Pattyn SR; Saerens EJ
    Zentralbl Bakteriol Orig A; 1975 May; 231(4):503-7. PubMed ID: 1101580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimycobacterial activities of two newer ansamycins, R-76-1 and DL 473.
    Ji BH; Chen JK; Lu XZ; Wang SY; Ni GX; Hou YH; Zhou DH; Tang QK
    Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):563-77. PubMed ID: 3546547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice.
    Ji B; Perani EG; Petinon C; Grosset JH
    Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):556-61. PubMed ID: 1338596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dapsone inhibition of the bactericidal action of rifampicin on Mycobacterium leprae in mice].
    Millan J; Moulia-Pelat JP
    Med Trop (Mars); 1989; 49(4):337-41. PubMed ID: 2695734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of 39 documented relapses of multibacillary leprosy after treatment with rifampin.
    Grosset JH; Guelpa-Lauras CC; Bobin P; Brucker G; Cartel JL; Constant-Desportes M; Flageul B; Frédéric M; Guillaume JC; Millan J
    Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):607-14. PubMed ID: 2674301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inadequate rifampicin treatment in multibacillary leprosy and the incubation time of relapse].
    Pattyn SR; Husser JA; Baquillon G; Grillone S; Van Loo G; Bourland J
    Acta Leprol; 1986; 4(3):301-2. PubMed ID: 3551469
    [No Abstract]   [Full Text] [Related]  

  • 7. Minimum inhibitory and bactericidal dosages of rifampici against Mycobacterium leprae in the mouse foot pad: relationship to serum rifampicin concentrations.
    Holmes IB
    Int J Lepr Other Mycobact Dis; 1974; 42(3):289-96. PubMed ID: 4617716
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined rifampin and dapsone chemotherapy of Mycobacterium leprae infection of the neonatally thymectomized Lewis rat.
    Fieldsteel AH; Levy L
    Int J Lepr Other Mycobact Dis; 1980 Sep; 48(3):267-76. PubMed ID: 7002811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The susceptibility testing of 13 strains of Mycobacterium leprae to rifampicin and the determination of minimal effective dosage.
    Wang HY; Li WZ; Ye GY; Yu LC; Shi MQ
    Lepr Rev; 1991 Sep; 62(3):276-9. PubMed ID: 1795586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent rifampicin therapy in lepromatous leprosy.
    Girdhar BK; Sreevatsa ; Desikan KV
    Lepr India; 1980 Jan; 52(1):89-96. PubMed ID: 6991816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further studies of the killing of M. leprae by aminoglycosides: reduced dosage and frequency of administration.
    Gelber RH
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):78-82. PubMed ID: 3549941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of some new quinolones and a combination of ofloxacin with rifampin against Mycobacterium leprae infection induced in athymic nude mice.
    Tomioka H; Saito H
    Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):250-4. PubMed ID: 8396614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of two doses of rifampin against Mycobacterium leprae.
    Husser JA; Traore I; Daumerie D
    Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):359-64. PubMed ID: 7963907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activity of rifabutin against Mycobacterium leprae.
    Yoder LJ; Jacobson RR; Hastings RC
    Lepr Rev; 1991 Sep; 62(3):280-7. PubMed ID: 1665534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
    Walker LL; Van Landingham RM; Shinnick TM
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of multidrug therapy in paucibacillary leprosy.
    Kar PK; Sohi AS
    J Indian Med Assoc; 1989 Feb; 87(2):34-6. PubMed ID: 2674283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
    Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
    Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo susceptibility of Mycobacterium leprae to ofloxacin either singly or in combination with rifampicin and rifabutin. Anti-leprosy activity of ofloxacin and ansamycins in mice.
    Dhople AM; Ibanez MA
    Arzneimittelforschung; 1994 Apr; 44(4):563-5. PubMed ID: 8011013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined regimens of one year duration in the treatment of multibacillary leprosy--I. Combined regimens with rifampicin administered during one year.
    Pattyn SR; Bourland J; Grillone S; Groenen G; Ghys P
    Lepr Rev; 1989 Jun; 60(2):109-17. PubMed ID: 2671559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An experimental study to evaluate the bactericidal activity of ofloxacin against an established Mycobacterium leprae infection.
    Banerjee DK; McDermott-Lancaster RD
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):410-5. PubMed ID: 1474279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.